The latest clinical guidelines from the American College of Gastroenterology aim to improve the diagnosis and treatment of ...

Rothenberg, Director of the Cincinnati Center for Eosinophilic Disorders and Professor of Pediatrics at Cincinnati Children's Hospital Medical Center, USA. At present, there are no approved drugs ...

Surgery has been limited to solving obstruction and small bowel perforation. Eosinophilic gastrointestinal disorders (EGID) constitute a pathology characterized by eosinophilic infiltration of the ...

Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells ...

Endoscopic biopsies are essential in cell-mediated disorders and allergic eosinophilic gastropathies. Treatment includes avoidance of the offending food by a restriction diet in children and the ...

as observed in eosinophilic gastroenteritis, atopic dermatitis, and in a heterogeneous group of rare disorders known as hypereosinophilic syndrome (HES). Most patients with HES are treated with ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a study published online Nov. 27 in The ...

Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.

Ruxolitinib phosphate is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Mepolizumab is currently approved under the brand name Nucala for maintenance treatment of severe asthma with an eosinophilic phenotype and chronic rhinosinusitis with nasal polyps, as well as for ...